We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mutant Protein Aggregates Drive Progression of ALS in Mouse Model

By LabMedica International staff writers
Posted on 16 May 2016
Print article
Image: Aggregated SOD1 protein can be seen as green dots in the cell fluid of a motor neuron in the spinal cord of an ALS patient. The red area is the nerve cell nucleus (Photo courtesy of Peter Andersen, Umeå University).
Image: Aggregated SOD1 protein can be seen as green dots in the cell fluid of a motor neuron in the spinal cord of an ALS patient. The red area is the nerve cell nucleus (Photo courtesy of Peter Andersen, Umeå University).
Researchers working with a mouse model of amyotrophic lateral sclerosis (ALS) have demonstrated that aggregates of mutated superoxide dismutase 1 (SOD1) can propagate the disease by progressing through nerve cells along the animal's spinal cord.

ALS is a specific disorder that involves the death of neurons. The disease, for which there is no cure, is characterized by stiff muscles, muscle twitching, and gradually worsening weakness due to muscles decreasing in size. Most ALS sufferers die from respiratory failure.

It has been shown that at the molecular level ALS was frequently caused by mutations in the gene encoding SOD1. Both patients and Tg mice expressing mutant human SOD1 (hSOD1) developed aggregates of unknown importance. In Tg mice, two different strains of hSOD1 aggregates (denoted A and B) have been identified; however, the role of these aggregates in disease pathogenesis has not been fully characterized.

Investigators at Umeå University (Sweden) prepared A and B hSOD1 strain aggregates by centrifugation through a density cushion. They then inoculated minute seeds of these substances into the lumbar spinal cords of 100-day-old mice carrying a human SOD1 Tg mutation.

Results published in the May 3, 2016, online edition of the Journal of Clinical Investigation revealed that mice seeded with A or B aggregates developed premature signs of ALS and became terminally ill after approximately 100 days, which was 200 days earlier than for mice that had not been inoculated or were given a control preparation. At the same time, exponentially growing strain A and B hSOD1 aggregations propagated throughout the spinal cord and brainstem, which resulted in the eventual death of the mice.

"The occurrence of SOD1 aggregates in nerve cells in ALS patients has been known for a while," said senior author Dr. Thomas Brännström, professor of pathology at Umeå University. "But it has long been unclear what role the SOD1 aggregates play in the disease progression in humans carrying hereditary traits for ALS. We have now been able to show that the SOD1 aggregates start a domino effect that rapidly spreads the disease up through the spinal cord of mice. We suspect that this could be the case for humans as well."

Related Links:
Umeå University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.